tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Frankel, 168 are a BUY (92.82%), 13 are a HOLD (7.18%).
Analyst Steve Frankel, currently employed at ROSENBLATT, carries an average stock price target met ratio of 54.04% that have a potential upside of 26.38% achieved within 175 days.
Steve Frankel’s has documented 358 price targets and ratings displayed on 11 stocks. The coverage is on Communication Services, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on IMAX, Imax Corp at 09-Sep-2026.
Analyst best performing recommendations are on QUOT (QUOTIENT TECHNOLOGY).
The best stock recommendation documented was for UTI (UNIVERSAL TECHNICAL INSTITUTE) at 11/13/2023. The price target of $11 was fulfilled within 3 days with a profit of $1.61 (17.15%) receiving and performance score of 57.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2023
$27.05
$0.01 (0.04%)
$45
3 years 1 months ago
(15-Aug-2023)
0/2 (0%)
$0.48 (1.81%)
Buy Since 15-Nov-2019
$27.05
$0.01 (0.04%)
$34
3 years 1 months 5 days ago
(10-Aug-2023)
8/11 (72.73%)
$0.39 (1.46%)
94
Hold Since 14-Nov-2018
$27
$-0.04 (-0.15%)
$30
3 years 1 months 5 days ago
(10-Aug-2023)
8/8 (100%)
$0.34 (1.28%)
49
Buy Since 01-May-2019
$53
3 years 1 months 5 days ago
(10-Aug-2023)
2/5 (40%)
$25.36 (91.75%)
394
Hold Since 12-Jul-2022
$27
$-0.04 (-0.15%)
$28
3 years 1 months 5 days ago
(10-Aug-2023)
4/4 (100%)
$0.34 (1.28%)
86
Which stock is Steve Frankel most bullish on?
Which stock is Steve Frankel most reserved on?
What Year was the first public recommendation made by Steve Frankel?
